Diazoxide choline controlled-release tablet

( DrugBank: Choline, Diazoxide / KEGG DRUG: Choline, Diazoxide )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
193	プラダー・ウィリ症候群	6

193. プラダー・ウィリ症候群

臨床試験数 : 113 / 薬物数 : 111 - (DrugBank : 26) / 標的遺伝子数 : 48 - 標的パスウェイ数 : 102

trials per page:

Showing 1 to 6 of 6 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04086810 (ClinicalTrials.gov)	October 2019	10/9/2019	An Open-Label Study of DCCR Tablet in Patients With PWS	An Open-Label Study of Diazoxide Choline Controlled-Release Tabletin Patients With Prader-Willi Synd ...	Prader-Willi Syndrome	Drug: DCCR	Soleno Therapeutics, Inc.	NULL	Withdrawn	4 Years	N/A	All	0	Phase 3	NULL
2	EUCTR2018-004216-22-GB (EUCTR)	25/09/2019	27/06/2019	A study to determine the safety of the study drug Diazoxide Choline Controlled-Release Tabletafter b ...	An Open-Label, Long-Term Safety and Efficacy Evaluation of Diazoxide Choline Controlled-Release Tabl ...	Hyperphagia associated with Prader-Willi Syndrome (PWS) MedDRA version: 20.0;Level: PT;Classificatio ...	Product Name: diazoxide choline Product Code: DCCR INN or Proposed INN: Diazoxide choline Other descrip ...	Soleno Therapeutics UK Ltd.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	105	Phase 3	United States;United Kingdom
3	EUCTR2018-004215-50-GB (EUCTR)	23/04/2019	12/08/2019	A study to evaluate the effects of a medicine named diazoxide choline in patients with the genetic d ...	A Randomized, Double-Blind, Placebo-Controlled Study of Diazoxide Choline Controlled-Release Tablet( ...	Hyperphagia associated with Prader-Willi Syndrome. MedDRA version: 20.0;Level: PT;Classification cod ...	Product Name: diazoxide choline Product Code: DCCR INN or Proposed INN: Diazoxide choline Other descrip ...	Soleno Therapeutics UK Ltd.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	105	Phase 3	United States;United Kingdom
4	NCT03440814 (ClinicalTrials.gov)	May 9, 2018	13/2/2018	A Study of Diazoxide Choline in Patients With Prader-Willi Syndrome	A Randomized, Double-Blind, Placebo-Controlled Study of Diazoxide Choline Controlled-Release Tablet( ...	Prader-Willi Syndrome	Drug: DCCR;Drug: Placebo for DCCR	Soleno Therapeutics, Inc.	NULL	Completed	4 Years	N/A	All	127	Phase 3	United States;United Kingdom
5	NCT02893618 (ClinicalTrials.gov)	July 2017	30/8/2016	A 5 Treatment Period Pharmacokinetic Study Evaluating Dose Proportionality and Food Effects of Diazo ...	A 5 Treatment Period Crossover Pharmacokinetic Study Evaluating Dose Proportionality and Food Effect ...	Prader-Willi Syndrome	Drug: Diazoxide choline controlled-release tablet	Essentialis, Inc.	NULL	Not yet recruiting	18 Years	65 Years	Both	32	Phase 2	NULL
6	NCT02034071 (ClinicalTrials.gov)	April 2014	8/1/2014	Clinical Study of Diazoxide Choline Controlled-Release Tablet(DCCR) in Patients With Prader-Willi Sy ...	A Dose Titration Study of Diazoxide Choline Controlled-Release Tablet(DCCR) in Patients With Prader- ...	Prader-Willi Syndrome	Drug: DCCR;Drug: Placebo	Essentialis, Inc.	NULL	Completed	10 Years	22 Years	Both	13	Phase 1/Phase 2	United States

First Previous1Next Last